Conclusion: Larger, well-designed head-to-head trials incorporating ABP outcomes are needed to clarify the relative effectiveness of different exercise strategies and to better inform evidence-based exercise prescription for blood pressure management. Registration:PROSPERO: CRD420251177743.
PubMed 42159444 ↗Kambo
People mainly take Kambo for mood. Based on 4 first-hand reports and 2 meta-analyses & systematic reviews in the medical literature. Ranked #2346 of 4,149 overall.
Of reports that state an outcome, 100% are positive.
What Kambo does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found.
Conclusion: Group interventions that promote breastfeeding by providing education, advice and support to mothers are likely cost-effective in England. Further research should enhance the evidence base on the clinical and cost-effectiveness of breastfeeding interventions, considering their differential effects on different socioeconomic groups and a wider range of clinical benefits of breastfeeding.
PubMed 41025939 ↗Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“The first time I had Kambo, my depression went away for about 3 days. The second time, it went away for a week. The third time, it went away for over two weeks.”
Other options for mood
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 3, 2026. How we rate